Insilico Medicine Announces Nature Medicine Publication of Phase IIa Results Evaluating Rentosertib, the Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis (IPF) Discovered and Designed with a Pioneering AI Approach
Phase IIa study results of Rentosertib were published simultaneously in Nature Medicine(IF = 58.7) and presented at the American Thoracic Society (ATS) 2025. Encouraging clinical data showed that patients receiving 60 mg QD Rentosertib experienced...
Alphamab Oncology Presented Multiple Clinical Data of Anti-HER2 Biparatopic ADC JSKN003 at the 2025 ASCO Annual Meeting
SUZHOU, China, June 3, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that multiple clinical data updates for anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 were presented as posters at the 2025 Annual Meeting of...
Mega Matrix Inc. Presented FlexTV Weekly Highlights from May 19 to 23, 2025, Featuring Desire Maze, Ethical Dilemmas and Breakthrough Manual
SINGAPORE, May 28, 2025 /PRNewswire/ -- Mega Matrix Inc. (NYSE American: MPU) launched seven English mini-series on its short drama platform FlexTV between May 19 and May 23, 2025, each illuminating life's myriad vicissitudes. Through tales of...
Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) Presented Preclinical Data on GNTnm-38, an Novel Epigenetic Immune Activator, at the 2025 ASCO Annual Meeting
TAIPEI, May 23, 2025 /PRNewswire/ -- GNTbm (stock code: 7427, Taiwan) announced the preclinical data on GNTbm-38, an novel epigenetic immune activator for cancer immunotherapy. GNTbm-38 was presented as posters at the 2025 American Association of...
Dot Inc. Presented 'Inclusive AI' Innovations at Microsoft Build 2025
Joining Microsoft's Copilot ecosystem, unveiling AI accessibility on the stage 'Dot Vista' demo shows tactile conversion of visual content by leveraging Windows AI APIs and Copilot+ PCs PowerPoint reimagined as a tactile interface for the visually...
Alphamab Oncology Presented Preclinical Data on Two Novel Bispecific ADCs at the 2025 AACR Annual Meeting
SUZHOU, China, April 30, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the preclinical data on two novel bispecific antibody-drug conjugates (ADCs) JSKN021 and JSKN022 were presented as posters at the 2025 American...
ImmVira Presented Clinical Results of Oncolytic Product MVR-C5252 Targeting Malignant Glioma via Convection-Enhanced Delivery at 2025 AACR Annual Meeting
SUZHOU, China, April 28, 2025 /PRNewswire/ -- From April 25 to April 30, 2025, U.S. time, ImmVira presented the Phase I clinical results of its oncolytic Herpes Simplex Virus ("oHSV") product MVR-C5252 targeting malignant glioma through poster...
Mega Matrix Inc. Presented FlexTV New Releases (March 31 - April 4): Springtime Sweet Romance - Contract Marriages, Reunited Lovers, and Family Revelations
SINGAPORE, April 10, 2025 /PRNewswire/ -- From March 31 to April 4, 2025, FlexTV, the global short-drama platform under Mega Matrix Inc. (NYSE American: MPU), released five new English-language dramas. From sweet twists in contract marriages to...
Remegen Announces Exciting Results of Telitacicept Phase 3 Clinical Trial for Patients with Generalized Myasthenia Gravis
YANTAI, China, April 9, 2025 /PRNewswire/ -- On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: 泰爱®) in patients with generalized...
LONGi and Raystech Presented at the 2025 Solar & Storage Live Exhibition
BRISBANE, Australia, March 28, 2025 /PRNewswire/ -- LONGi has partnered with Raystech to make a significant appearance at the Solar & Storage Live exhibition, held on March 26-27, 2025, following the announcement of Raystech as the exclusive...